Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Revaleskin is a professional-grade topical skincare line formulated with CoffeeBerry extract, derived from the whole fruit of the *Coffea arabica* plant. Developed by Stiefel Laboratories, the product line is primarily indicated for anti-aging and the treatment of photoaged skin. The mechanism of action centers on the high concentration of polyphenols found in the CoffeeBerry extract, including chlorogenic acid, ferulic acid, and quinic acid, which act as potent antioxidants. These compounds neutralize reactive oxygen species (ROS) and free radicals generated by UV exposure and environmental pollutants. By reducing oxidative stress, Revaleskin helps prevent collagen degradation and inflammatory responses in the dermis, leading to improvements in the appearance of fine lines, wrinkles, and hyperpigmentation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Revaleskin.